Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Jul-24 5:04 PM View:  | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 22-Jul-24 | Sale | 69,005 | $8.03 | $554,170.00 | (69%) 100.32K to 31.32K | |
| 23-Jul-24 5:04 PM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 19-Jul-24 | Sale | 60,201 | $7.21 | $434,325.00 | (38%) 160.52K to 100.32K | |
| 19-Jul-24 11:12 AM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 18-Jul-24 | Sale | 38,576 | $6.93 | $267,332.00 | (19%) 199.1K to 160.52K | |
| 19-Jul-24 11:12 AM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 17-Jul-24 | Sale | 3,207 | $6.91 | $22,160.40 | (2%) 202.31K to 199.1K | |
| 17-Jul-24 6:11 PM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 16-Jul-24 | Sale | 50,000 | $7.13 | $356,500.00 | (20%) 252.31K to 202.31K | |
| 16-Jul-24 6:14 PM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 15-Jul-24 | Sale | 42,377 | $7.01 | $297,063.00 | (14%) 294.68K to 252.31K | |
| 16-Jul-24 6:14 PM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 12-Jul-24 | Sale | 50,000 | $7.07 | $353,500.00 | (15%) 344.68K to 294.68K | |
| 11-Jul-24 8:45 PM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 11-Jul-24 | Sale | 50,000 | $7.11 | $355,500.00 | (13%) 394.68K to 344.68K | |
| 11-Jul-24 8:45 PM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 10-Jul-24 | Sale | 50,000 | $6.83 | $341,500.00 | (11%) 444.68K to 394.68K | |
| 11-Jul-24 8:45 PM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 09-Jul-24 | Sale | 5,931 | $6.66 | $39,500.50 | (1%) 450.61K to 444.68K | |
| 09-Jul-24 4:46 PM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 05-Jul-24 | Sale | 12,342 | $7.06 | $87,134.50 | (3%) 462.96K to 450.61K | |
| 03-Jul-24 2:42 PM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 03-Jul-24 | Option Sale | 7,649 | $6.76 | $51,707.20 | (1%) 512.96K to 505.31K | |
| 03-Jul-24 2:42 PM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 03-Jul-24 | Sale | 42,351 | $6.76 | $286,293.00 | (8%) 505.31K to 462.96K | |
| 03-Jul-24 2:42 PM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 01-Jul-24 | Option Exercise | 7,649 | $0.00 | $1.53 | 2% 505.31K to 512.96K | |
| 01-Jul-24 9:29 PM View: | Ra Capital Management, LLC Director 10% Owner | Eliem Therapeutics, Inc. (ELYM) | 27-Jun-24 | Grant | 5,259,870 | -- | -- | 40% 13.15M to 18.41M | |
| 01-Jul-24 9:29 PM View: | Ra Capital Management, LLC Director 10% Owner | Eliem Therapeutics, Inc. (ELYM) | 27-Jun-24 | Purchase | 13,008,500 | $3.84 | $49,952,800.00 | 71% 18.41M to 31.42M | |
| 27-Jun-24 7:03 PM View: | Thomas Stephen Basil Director | Eliem Therapeutics, Inc. (ELYM) | 27-Jun-24 | Grant | 103,907 | -- | -- | 100% 0 to 103.91K | |
| 21-Jun-24 2:57 PM View: | Pimblett Emily Chief Accounting Officer | Eliem Therapeutics, Inc. (ELYM) | 20-Jun-24 | Option Sale | 1,245 | $7.21 | $8,982.05 | (25%) 5.0K to 3.75K | |
| 21-Jun-24 2:57 PM View: | Pimblett Emily Chief Accounting Officer | Eliem Therapeutics, Inc. (ELYM) | 18-Jun-24 | Option Exercise | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 08-Apr-24 5:33 PM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 05-Apr-24 | Option Exercise | 17,847 | $0.00 | $3.57 | 4% 487.46K to 505.31K | |
| 04-Mar-24 11:07 AM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 20-Sep-23 | Option Exercise | 20,728 | $0.00 | $13.92 | 4% 466.73K to 487.46K | |
| 14-Mar-23 5:04 PM View: | Morisset Valerie EVP, R&D and CSO | Eliem Therapeutics, Inc. (ELYM) | 10-Mar-23 | Option Exercise | 316,410 | $0.00 | $522.68 | 210% 150.32K to 466.73K | |
| 16-Aug-21 4:21 PM View: | Ai Eti LLC 10% Owner | Eliem Therapeutics, Inc. (ELYM) | 12-Aug-21 | Conversion | 4,209,400 | -- | -- | 100% 0 to 4.21M | |
| 16-Aug-21 4:21 PM View: | Ai Eti LLC 10% Owner | Eliem Therapeutics, Inc. (ELYM) | 12-Aug-21 | Purchase | 800,000 | $12.50 | $10,000,000.00 | 19% 4.21M to 5.01M |
